About PepKon
PepKon is a company based in Paris (France) founded in 2022 by Jean Pascal Tranie and Patric Weil. It operates as a B2B, and Partnership-based. PepKon offers products and services including PepKon Platform and TSP-1/CD47 Peptides. PepKon operates in a competitive market with competitors including Adicet Bio, Orca Bio, Ossium Health, ImmunoACT and Nordic Nanovector, among others.
- Headquarter Paris, France
- Founders Jean Pascal Tranie, Patric Weil
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PepKon
PepKon offers a comprehensive portfolio of products and services, including PepKon Platform and TSP-1/CD47 Peptides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-based tool for designing and testing oncology peptides.
Peptides targeting cancer pathways for improved treatment.
Funding Insights of PepKon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PepKon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PepKon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pepkon Comparisons
Competitors of PepKon
PepKon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adicet Bio, Orca Bio, Ossium Health, ImmunoACT and Nordic Nanovector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immune cell therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Ossium Health is focused on bioengineering for improved health.
|
|
| domain | founded_year | HQ Location |
Cell therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody radionuclide conjugates are developed for haematological cancers.
|
|
| domain | founded_year | HQ Location |
Developer of cancer therapeutics for the treatment of blood cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PepKon
When was PepKon founded?
PepKon was founded in 2022.
Where is PepKon located?
PepKon is headquartered in Paris, France.
What does PepKon do?
PepKon is a biotechnology firm that designs and tests first-in-class peptides for oncology, addressing limitations in current cancer therapies through a platform integrating biology, chemistry, and artificial intelligence. They optimize drug candidates and target pathways like TSP-1CD47, collaborating with international partners and outsourcing preclinical studies. Based in Louveciennes, France, they advance innovations toward clinical trials, aiming for safer treatments without promotional claims.
Who are the top competitors of PepKon?
PepKon's top competitors include Orca Bio, Ossium Health and Adicet Bio.
What products or services does PepKon offer?
PepKon offers PepKon Platform and TSP-1/CD47 Peptides.